Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet K Samur

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Blood|January 14, 2017
p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myelomaTeru Hideshima, Francesca Cottini, Yoshihisa Nozawa, et al.
Gastroenterology|May 13, 2023
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal AdenocarcinomaSubodh Kumar, Jiangning Zhao, Srikanth Talluri, et al.
Cancers|July 2, 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple MyelomaYanira Ruiz-Heredia, Alejandra Ortiz-Ruiz, Mehmet K Samur, et al.
Blood Cancer Discovery|September 27, 2021
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationAnnamaria Gulla, Eugenio Morelli, Mehmet K Samur, et al.
Science Advances|June 5, 2021
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironmentJiye Liu, Teru Hideshima, Lijie Xing, et al.
Cancer Research|September 15, 2019
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer CellsTsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, et al.
Leukemia|November 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset casesMaroulio Pertesi, Delphine Demangel, Abhishek Niroula, et al.
Nature Communications|January 6, 2016
The KDM3A-KLF2-IRF4 axis maintains myeloma cell survivalHiroto Ohguchi, Teru Hideshima, Manoj K Bhasin, et al.
Blood|August 4, 2025
Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myelomaJoshua Rivera, Qi Yan, Saeed Daneshmandi, et al.
Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Blood|January 14, 2017
p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myelomaTeru Hideshima, Francesca Cottini, Yoshihisa Nozawa, et al.
Gastroenterology|May 13, 2023
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal AdenocarcinomaSubodh Kumar, Jiangning Zhao, Srikanth Talluri, et al.
Cancers|July 2, 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple MyelomaYanira Ruiz-Heredia, Alejandra Ortiz-Ruiz, Mehmet K Samur, et al.
Blood Cancer Discovery|September 27, 2021
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationAnnamaria Gulla, Eugenio Morelli, Mehmet K Samur, et al.
Science Advances|June 5, 2021
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironmentJiye Liu, Teru Hideshima, Lijie Xing, et al.
Cancer Research|September 15, 2019
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer CellsTsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, et al.
Leukemia|November 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset casesMaroulio Pertesi, Delphine Demangel, Abhishek Niroula, et al.
Nature Communications|January 6, 2016
The KDM3A-KLF2-IRF4 axis maintains myeloma cell survivalHiroto Ohguchi, Teru Hideshima, Manoj K Bhasin, et al.
Blood|August 4, 2025
Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myelomaJoshua Rivera, Qi Yan, Saeed Daneshmandi, et al.
Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.
Pageof 5